For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Blog
State Directed Payments redistribute money across states and supercharged growth
Differences in states’ use of SDPs cause an interstate redistribution of taxes as well. Because states are setting different levels of SDPs, spending varies…
Search Posts
Blog
Senate Democrats Block Anti-Zika Bill Yet Again
Democrats in the Senate have blocked a bill that would have provided federal funds to combat the spread of the Zika virus, reports The Hill.
Blog
New Drug Price Proposal Light on Competition, Heavy on Bureaucracy
Last Friday, Hillary Clinton announced a new plan to “respond to unjustified price hikes” on certain pharmaceutical drugs.
Blog
Obamacare Shrinks Economy through Medicaid Expansion and Tax Credit Cliffs
Obamacare’s expansion of Medicaid reduced employment in those states that participated in it by a statistically significant extent, according to a recent study by Georgetown’s…
Blog
RealClear Radio Hour: American Indian, EpiPen, and Free Speech Fiascos
In this episode of RealClear Radio Hour, we discuss the fiascos of government overreach and overregulation—on American Indian reservations, in the EpiPen saga, and with…
Blog
CEI Files Opening Brief in “Vapes on a Plane” Lawsuit
Today, CEI filed its opening brief against the U.S. Department of Transportation (DOT), Office of the Secretary of Transportation’s March final rule prohibiting electronic cigarette…
Blog
Q&A on the FDA’s New E-Cigarette Rules
After years of waiting and fighting, the new rules put forth by the U.S. Food and Drug Administration (FDA) on electronic cigarettes and other non-cigarette…